Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...

Wider use of continuous glucose monitoring (CGM), glycemic management during cancer treatment, and individualized dosing of obesity drugs in people with diabetes are just a few of the new topics and ...

Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...